Cargando…

Diabetes, Hypertension, and Outcome Studies: Overview 2010

Detalles Bibliográficos
Autores principales:	Nilsson, Peter M., Cederholm, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Diabetes, Obesity and Hypertension Outcome Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632146/ https://www.ncbi.nlm.nih.gov/pubmed/21525440 http://dx.doi.org/10.2337/dc11-s204

Ejemplares similares

Sibutramine on Cardiovascular Outcome
por: Scheen, André J.
Publicado: (2011)

The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analyses
por: Ginsberg, Henry N.
Publicado: (2011)

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs
por: Hirshberg, Boaz, et al.
Publicado: (2011)

Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?
por: Nilsson, Peter M.
Publicado: (2009)

Hypertension and chronic kidney disease in Asian populations
por: Teo, Boon Wee, et al.
Publicado: (2021)

Characteristics of hypertension in obstructive sleep apnea: An Asian experience
por: Hoshide, Satoshi, et al.
Publicado: (2021)

Hypertension in a multi‐ethnic Asian population of Singapore
por: Chan, Gek Cher, et al.
Publicado: (2020)

Hypertension and erectile dysfunction: The role of endovascular therapy in Asia
por: Wang, Tzung‐Dau, et al.
Publicado: (2020)

Hypertension and stroke in Asia: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2020)

Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
por: Minh, Huynh Van, et al.
Publicado: (2021)

Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network
por: Turana, Yuda, et al.
Publicado: (2020)

White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
por: Bursztyn, Michael, et al.
Publicado: (2009)

Hypertension and Diabetes: What are the pros to treating early surrogates?
por: Schmieder, Roland E.
Publicado: (2009)

Should White-Coat Hypertension in Diabetes Be Treated? Pro
por: Mancia, Giuseppe, et al.
Publicado: (2009)

Use of machine-learning algorithms to determine features of systolic blood pressure variability that predict poor outcomes in hypertensive patients
por: Lacson, Ronilda C, et al.
Publicado: (2018)

Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes
por: Parati, Gianfranco, et al.
Publicado: (2013)

Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies
por: Parati, Gianfranco, et al.
Publicado: (2011)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

Prevalence of hypertensive disorders during pregnancy in France (2010‐2018): The Nationwide CONCEPTION Study
por: Olié, Valérie, et al.
Publicado: (2021)

Most Recent Trials and Advances in Hypertension
por: Rey-Rañal, Elías Martínez, et al.
Publicado: (2022)

Hypertension : physiopathology and treatment /
Publicado: (1977)

Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension
por: Grossman, Ehud
Publicado: (2013)

The chaos of hypertension guidelines for chronic kidney disease patients
por: Castillo-Rodriguez, Esmeralda, et al.
Publicado: (2019)

The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management
por: Cappuccio, Francesco P
Publicado: (2020)

Familial history of hypertension as a predictor of increased arterial stiffness in normotensive offspring
por: Youssef, Ghada, et al.
Publicado: (2017)

Long sleep duration and cardiovascular disease: Associations with arterial stiffness and blood pressure variability
por: Matsubayashi, Hideaki, et al.
Publicado: (2020)

Endothelial Factors and Diabetic Nephropathy
por: Karalliedde, Janaka, et al.
Publicado: (2011)

RAS Blockade for Every Diabetic Patient: Pro and Con
por: Ruilope, Luis M., et al.
Publicado: (2011)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
por: Avogaro, Angelo, et al.
Publicado: (2011)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Treatment of Prehypertension in Diabetes and Metabolic Syndrome: What are the pros?
por: Segura, Julian, et al.
Publicado: (2009)

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?
por: Mancia, Giuseppe, et al.
Publicado: (2011)

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
por: Ritz, Eberhard
Publicado: (2011)

How to Define Prehypertension in Diabetes/Metabolic Syndrome
por: Leibowitz, Avshalom, et al.
Publicado: (2009)

Should We Treat Prehypertension in Diabetes?: What are the cons?
por: Grossman, Ehud
Publicado: (2009)

Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?
por: Parati, Gianfranco, et al.
Publicado: (2009)

The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension
por: Wronski, Samantha L., et al.
Publicado: (2019)

Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates?
por: Rabizadeh, Soghra, et al.
Publicado: (2021)

Impact of weight bias and stigma on quality of care and outcomes for patients with obesity
por: Phelan, SM, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m775l5m2gon9v94oeuipcv0coh